3Z-20-005

About 3Z Pharmaceuticals

3Z Pharmaceuticals is an innovative, private biotech firm utilizing a proprietary, behavior-based zebrafish screening technology to accelerate drug discovery for CNS disorders through a repurposing strategy. Its pipeline consists of five preclinical programs targeting various neurological conditions, aiming to reduce development time and risk by leveraging existing safety and approval data. The company is led by a small, experienced team with deep expertise in behavioral neuroscience and operates in a pre-revenue, preclinical stage, positioning it as a platform company with a focused therapeutic development model.

Therapeutic Areas

Other Neurological Indication (Undisclosed) Drugs